CAS: 115029-24-8; 2-Fluoro-4-(Trifluoromethyl)Benzoic Acid

该化合物是一种芳烃式的盒状碳酸,其特点是氟原子和附于苯化酸结构的三氟甲基组的特性.该化合物的分子分子式为C8H4F4O2,表明它含有8个碳原子,4个氟化原子,4个氢原子和2个氧原子.该化合物在室温中一般表现出固态,并因其与箱酸功能组有关的分子力量强而具有较高的熔点而闻名.多种氟化原子的存在有助于其独特的化学特性,包括增加脂性以及药物和农用化学品的潜在应用.此外,氟化组可以增强化合物在各种化学反应中的稳定性和再活性.与许多氟化化合物一样,它可能具有低的挥发性,对降解具有较高的耐受力,因此对工业和研究环境都有兴趣.应当参考安全数据,以便处理该物质及其潜在危害.

结构式图片

相似化合物

146070-34-0 197239-49-9 89763-93-9

欧盟法规

ECHA物质C&L通报

上下游产品

2-chloro-4-(trifluoromethyl)benzoic acid 2-[3-(5-[(2-Fluoro-4-trifluoromethylbenzoyl)-amino]methyl-6-ethoxy-pyridin-3-yl)phenyl]acetic acid H-[1,3,4]oxadiazol-2-one5-(2-fluoro-4-trifluoromethyl-phenyl)-3H-[1,3,4]oxadiazol-2-one 3-[(5-chloro-2-methoxy-phenyl)methyl]-5-[2-fluoro-4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-(3H)-one 3-[(5-chloro-2-methoxyphenyl)methyl]-5-[2-(1H-imidazol-1-yl)-4-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-(3H)-one

合成工艺路线路线简述

    📜2-氯-4-三氟甲基苯甲酸置于18-冠醚-6,Potassium Fluoride Dihydrate体系中,用 1,3-二噁烷 用作溶剂,以11.8 G的收率获得2-氟-4-三氟甲基苯甲酸
    参考文献:一种合成2-氟-4-三氟甲基苯甲酸的方法
    标题:一种合成2-氟-4-三氟甲基苯甲酸的方法
    摘要:本发明公开了一种合成2‑氟‑4‑三氟甲基苯甲酸的方法.以间氯三氟甲苯原料,与2,2,6,6‑四甲基哌啶氯化镁或2,2,6,6‑四甲基哌啶锂选择性去质子后,通入二氧化碳生成2‑氯‑4‑三氟甲基苯甲酸,接着氟化钾亲核取代后得到2‑氟‑4‑三氟甲基苯甲酸.该方法原料易得,步骤短,反应选择性高,具有潜在的工业化放大前景.

    海关参考信息

    专利信息


    专利号:WO-2025077857-A1
    优先权日:2023-10-13
    标题:Use of prmt5 inhibitor in treatment of tumors or cancers
    发明人:YAO BING; GU XIAOHUI; MAO WEIFENG; ASWAD FRED JULLIEN; JOSEPH JAMES DAVID; LI MINGXI
    权利人:SHANGHAI APEIRON THERAPEUTICS COMPANY LTD
    摘要:The present disclosure describes a novel molecule having protein arginine methyltransferase 5 inhibitory activity, and methods for synthesis and use of a compound. Specifically, the present disclosure describes a compound of formula (I) or a pharmaceutically acceptable salt, hydrate or solvate thereof, and methods for synthesis and use of the compound.

    专利号:US-9217012-B2
    优先权日:2009-04-08
    标题 :Inhibitors of protein tyrosine phosphatases
    发明人:ZHANG ZHONG-YIN; ZHANG SHENG
    权利人:ZHANG ZHONG-YIN; ZHANG SHENG; UNIV INDIANA RES & TECH CORP
    摘要:Disclosed herein are compounds that selectively inhibit members of the PTP family of enzymes. Synthesized compounds demonstrated selective inhibition of TC-PTP. Also provided are methods of using the compounds and formulations containing the compounds. Also described is a fluorescence-tagged combinatorial library synthesis and screening method. And methods of using these compounds to effect enzyme activity both in cells and in vitro as well as method of using these compounds to treat diseases in human and animals.

    专利号:US-7189749-B2
    优先权日:1999-06-25
    标 题 :Substituted phenoxyacetic acids
    发明人:VAN ZANDT MICHAEL C
    权利人:INST FOR PHARM DISCOVERY INC
    摘要:Disclosed are substituted phenoxyacetic acids useful in the treatment of chronic complications arising from diabetes mellitus. Also disclosed are pharmaceutical compositions containing the compounds, alone or in combination with other therapeutic agents, and methods of treatment employing the compounds and pharmaceutical compositions, as well as methods for their synthesis.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    [参考文献]: F Y Ghauri, Et Al. Quantitative Structure-Metabolism Relationships For Substituted Benzoic Acids In The Rat. Computational Chemistry, Nmr Spectroscopy And Pattern Recognition Studies. Biochem Pharmacol. 1992 Nov 17;44(10):1935-46.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知